ReviewFrontiers in medicine2026

Microbial metabolites and the gut-lung axis in non-small cell lung cancer immunotherapy: evidence boundaries and translational implications.

Fangxiong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.